Top Stories

Kyra Ventures leads a $5 million investment round for Medway Hospitals in Chennai

 Kyra Ventures leads a $5 million investment round for Medway Hospitals in Chennai


Kyra Ventures leads a $5 million investment round for Medway Hospitals in Chennai
Kyra Ventures leads a $5 million investment round for Medway Hospitals in Chennai



Approximately 500 beds are now available for the chain at all sites, with 50–100 beds available in each of its eight units.


At the moment, eight hospitals in Tamil Nadu and Seemandhra are run under the multispecialty hospital network Medway Hospitals.

According to a statement from the hospital, Medway Hospitals, a multispecialty hospital network with its headquarters in Chennai, has successfully raised $5 million in its first round of institutional equity capital.


Leading the round was Kyra Ventures, with family offices also participating.


At the moment, eight hospitals in Tamil Nadu and Seemandhra are run under the multispecialty hospital network Medway Hospitals. Critical care, orthopedics, neurology, nephrology, neurosurgery, organ transplant, pulmonology, urology, and more are among its tertiary care offerings. It also has a specialized center that treats cardiovascular illnesses (CVD).


Currently, the chain has 500 beds total spread across all of its sites, with 50–100 beds in each unit.


The first independent heart institute in South India to be accredited by both JCI and NABH, Medway opened a cutting-edge heart institute in Chennai in 2021. In only two years, Medway Heart Institute has successfully completed over 1,000 heart operations and 3,000 cath lab treatments.


Since the beginning of its organ transplant program in 2021, Medway has successfully completed more than 150 kidney transplants.


Under the direction of internal medicine and critical care expert Dr. T. Palaniappan, Medway Hospitals commenced operations in 2012.


According to a recent report by Bain Capital, India has become a significant participant in the Asia-Pacific area and is expected to account for around 30% of the region's share of global health care transaction activity in 2023.


No comments: